Fibroblast growth factor 23 quantification in serum or plasma, requested by a specialist or consultant physician to determine eligibility for a relevant treatment listed on the Pharmaceutical Benefits Scheme
Fibroblast growth factor 23 quantification in serum or plasma, requested by a specialist or consultant physician to determine eligibility for a relevant treatment listed on the Pharmaceutical Benefits Scheme
| Release | Change | Old | New |
|---|---|---|---|
| November 2025 | Listed | — | $90.0 |
Data sourced from Australian Government publications · Not an official government service